Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia

British Journal of Haematology

Volumn 97, Issue 3, 1997, Pages 662-665

  Schwartz, Stefan ^b   Milatovic, Dana ^a   Thiel, Eckhard ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Aspergillus; azoles; brain abscess; immunosuppression; voriconazole

Indexed keywords

VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; BRAIN ABSCESS; CASE REPORT; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; INFECTION RISK; MALE; PRIORITY JOURNAL;

EID: 0030989573     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.972911.x     Document Type: Article

References (9)

1. Coleman, J.M., Hogg, G.G., Rosenfeld, J.V. & Waters, K.D. (1995) Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery: case report and review of the literature. Neurosurgery, 36, 858-863.
2. Collette, N., Van der Auwera, P., Meunier, F., Lambert, C., Sculier, J.P. & Coune, A. (1991) Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. Journal of Antimicrobial Chemotherapy, 27, 535-548.
3. Collette, N., Van der Auwera, P., Pascual Lopez, A., Heymans, C. & Meunier, F. (1989) Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-desoxycholate. Antimicrobial Agents and Chemotherapy, 33, 362-368.
4. Como, J.A. & Dismukes, W.E. (1994) Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine, 330, 263-272.
5. Denning, D., del Favero, A., Gluckman, E., Norfolk, D., Ruhnke, M., Yonren, S., Troke, P. & Sarantis, N. (1995) UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis. (Abstract). 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, F80, 126.
6. Denning, D.W. & Stevens D.A. (1990) Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Reviews of Infectious Diseases, 12, 1147-1201.
7. Francis, P. & Walsh, T.J. (1992) Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clinical Infectious Diseases, 15, 1003-1018.
8. Jezequel, S.G., Clark, M., Evans, K., Roffey, S., Wastall, P. & Webster, R. (1995) UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: disposition in animals. (Abstract). 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, F77, 126.
9. Ribrag, V., Dreyfus, F., Venot, A., Leblong, V., Lanore, J.J. & Varet, B. (1993) Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leukemia and Lymphoma, 10, 317-321.